Overview

Effect of Cyclosporine on the Pharmacokinetics (PK) of AT-527 (R07496998)

Status:
Completed
Trial end date:
2021-05-10
Target enrollment:
Participant gender:
Summary
This study will determine the effect of cyclosporine on the PK of AT-527 (R07496998) in healthy male subjects
Phase:
Phase 1
Details
Lead Sponsor:
Atea Pharmaceuticals, Inc.
Collaborator:
Hoffmann-La Roche
Treatments:
Cyclosporine
Cyclosporins